Moving in a bid to address the supply shortage of medical products brought about by the novel coronavirus, the U.S…....
Please subscribe to read the full story.
Coronavirus
Coronavirus Report: Part 25 – Operations Bounce Back in China for Paraxylene Derivatives
Impact from the novel coronavirus appears to be diminishing with respect to the paraxylene (PX) chain. China’s restrictions on logistics…...
Please subscribe to read the full story.
Coronavirus Report: Part 24 – Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
The Chemical Daily recently sent out a survey to major Japanese pharmaceutical firms engaged in the R&D of new drugs,…...
Please subscribe to read the full story.
